Biologic Videos
-
A Systematic Approach To Assess Biologics Developability
5/8/2026
Discover how a systematic, data-driven developability workflow can accelerate biologic formulation development, identify risks earlier, and optimize stability and manufacturability.
-
From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing
5/8/2026
Explore how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding and informed decision-making.
-
Spray Dried Biologics For Pulmonary Dosage Forms
5/8/2026
View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.
-
Asymchem Group – A Fully Integrated CDMO Partner For The Global Pharmaceutical Industry
5/7/2026
Smarter chemistry and process design enable sustainable manufacturing. Modern methods reduce waste and energy use while maintaining efficiency and high‑quality pharmaceutical production.
-
From Clinical To Commercial: Asymchem's Cartridge Filling Capabilities In 30s
5/7/2026
Automated cartridge filling and integrated manufacturing help reduce risk, simplify scale‑up, and support a smoother transition from clinical development to commercial production.
-
Early Developability Assessment For Antibody Based Therapeutics
5/7/2026
Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.
-
Using Full DEL Data To Improve Early Compound Decisions
4/29/2026
High-throughput screens hold insights beyond individual hits. Examine a broader view of screening data that reveals structure–function patterns to guide smarter compound prioritization.
-
Simtra Capabilities Update April 2026: Fill/Finish
4/28/2026
A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.
-
Upperton Capabilities Update April 2026: Fill/Finish
4/28/2026
An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.
-
Grand River Aseptic Manufacturing Capabilities Update April 2026: Fill/Finish
4/28/2026
A sterile injectable CDMO providing fill‑and‑finish services across vials, syringes, and cartridges, supported by isolator-based filling lines and biologics-ready scale.